WEKO3
アイテム
女性における高血圧 : 診断と治療
http://hdl.handle.net/10470/26242
http://hdl.handle.net/10470/26242fdfe9652-0f72-458a-b1f2-4fe507605931
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
KJ00006019242.pdf (879.3 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2010-08-10 | |||||
| タイトル | ||||||
| タイトル | 女性における高血圧 : 診断と治療 | |||||
| 言語 | ||||||
| 言語 | jpn | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 別タイトル | ||||||
| その他のタイトル | Hypertension in Women : Diagnosis and Treatment | |||||
| 著者名 |
成瀬, 光栄
× 成瀬, 光栄× 田辺, 晶代× 高木, 佐知子× 高野, 加寿恵 |
|||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 296272 | |||||
| 姓名 | NARUSE, Mitsuhide | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 296273 | |||||
| 姓名 | TANABE, Akiyo | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 296274 | |||||
| 姓名 | TAKAGI, Sachiko | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 296275 | |||||
| 姓名 | TAKANO, Kazue | |||||
| 出版者 | ||||||
| 出版者 | 東京女子医科大学学会 | |||||
| 受付日付 | ||||||
| 日付 | 2010-08-10 | |||||
| 日付タイプ | Created | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0040-9022 | |||||
| NCID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AN00161368 | |||||
| 書誌情報 |
東京女子医科大学雑誌 巻 73, 号 7, p. 205-213, 発行日 2003-07-25 |
|||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | There is no gender difference in the principle of the diagnosis and treatment of hypertension. Hypertension in women is however characterized by its causes of hypertension, relation to obesity, and influences of pregnancy and menopause. Endocrine hypertension such as primary aldosteronism and Cushing' s syndrome is much more common in women than men. Obesity could be more closely correlated to blood pressure increase in women. Special care should be taken in the treatment of hypertension of the pregnant women. Those commonly utilized agents such as angiotensin converting enzyme inhibitors and Ca channel antagonists are basically contraindicated. Difficulties in controlling hypertension are often experienced with hydralazine and a-methyl dopa as the recommended first line agents. Incidence of hypertension is significantly increased in the postmenopausal women. Changes in life style and social circumstance are involved in the development of hypertension in addition to the estrogen deficiency as the major endocrine background. The postmenopausal hypertension has an increasing impact on the quality of life in women because of the significant elongation of the life span. Antihypertensive agents as well as life style modification considering the pathophysiology are needed. Hormone replacement therapy is not recommended solely for the purpose of blood pressure control. Close interrelationship are warranted between internists and obstetricians/gynecologists in any aspects of hypertension in women. | |||||
| 著者所属 | ||||||
| 値 | 東京女子医科大学医学部第二内科学 | |||||
| 著者所属 | ||||||
| 値 | 東京女子医科大学医学部第二内科学 | |||||
| 著者所属 | ||||||
| 値 | 東京女子医科大学医学部第二内科学 | |||||
| 著者所属 | ||||||
| 値 | 東京女子医科大学医学部第二内科学 | |||||
| 著者キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | endocrine hypertension | |||||
| 著者キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | obesity | |||||
| 著者キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | pregnancy | |||||
| 著者キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | postmenopausal hypertension | |||||
